Industry
Nearly half of U.S. obesity drug users did not follow prescription rules, survey finds
About 1 in 10 U.S. adults used GLP-1 drugs for obesity or diabetes treatment, a survey by the U.S. Centers for Disease Control and Prevention found. Among 976 users, 44 percent said they used the drugs differently from prescriptions, most commonly skipping doses. Users cited cost and supply problems as reasons. Use of compounded GLP-1 drugs was also reported, and those users were more likely to deviate from prescriptions.